Intraoperative Imaging Market Size, Share, Growth, and Industry Analysis, By Type (Intraoperative CT,Intraoperative MRI,Intraoperative Ultrasound), By Application (Neurosurgery,Spinal Surgery,Orthopedic Surgery,Others), Regional Insights and Forecast to 2035
Intraoperative Imaging Market Overview
The global Intraoperative Imaging Market is forecast to expand from USD 128.07 million in 2026 to USD 138.06 million in 2027, and is expected to reach USD 251.7 million by 2035, growing at a CAGR of 7.8% over the forecast period.
Home medical equipment (HME), also known as home health equipment or durable medical equipment (DME), consists of devices used by patients in non-clinical settings (homes, assisted living) for monitoring, therapy, or daily assistance. The global Intraoperative Imaging Market reached approximately USD 45.35 billion in 2024 per one research source. The number of units shipped globally for respiratory devices alone surpassed 8.2 million units in 2023. The segment for mobility aids (wheelchairs, walkers) accounted for more than 20% of total unit demand in 2024.
In the United States, the Intraoperative Imaging Market is highly mature and penetrated. The U.S. durable medical equipment segment had a total market size of about USD 66.81 billion in 2024 (for DME broadly) according to a major analysis. The HME rentals industry in the U.S. is estimated at USD 5.7 billion for 2025. Home oxygen and respiratory therapy equipment account for more than 45% of rental units in the U.S. market. The largest U.S. distributor, Lincare Holdings, serves approximately 1.8 million patients via over 700 locations.
Key Findings
- Market Growth Potential: The global Intraoperative Imaging Market size is estimated at USD 45,192.47 million in 2025 and projected to reach USD 88,141.6 million by 2034, expanding at a CAGR of 7.71%.
- Key Market Driver: Aging population remains the primary growth driver, with over 720 million people aged 65+ worldwide in 2023, representing nearly 9.2% of the global population.
- Major Market Restraint: High device costs and reimbursement gaps limit adoption, as 40% of patients in emerging markets cite affordability issues and 35% rely on refurbished or rental equipment.
- Emerging Trends: Connected and IoT-enabled devices are accelerating adoption, with 28% of new HME products launched in 2024 featuring integrated remote monitoring capabilities.
- Regional Leadership: North America leads with 35% market share, followed by Asia-Pacific at 28%, Europe at 25%, and Middle East & Africa collectively holding 12%.
- Competitive Landscape: Top companies dominate strongly, with the top two global players (GE Healthcare and Siemens Healthineers) collectively holding 37% of the imaging-focused HME segment share.
- Market Segmentation: Respiratory care devices, sleep therapy equipment, and mobility aids represent over 55% of total units shipped in 2024 across the Home Medical Equipment Market.
- Recent Developments: Between 2023 and 2025, more than 35 new smart home medical devices were launched globally, of which 18 devices incorporated AI-based monitoring or predictive features.
Intraoperative Imaging Market Latest Trends
In recent years, the Intraoperative Imaging Market Trends have been shaped by rising penetration of connected, IoT-enabled devices, especially remote patient monitoring (RPM) units. For instance, shipments of IoT-enabled blood pressure monitors grew by 28% year-on-year in 2023. Sleep therapy devices (CPAP, BiPAP) in home settings registered a growth in unit shipments by 15% in 2024. The Home Medical Equipment Industry Report also notes expansion in rental-to-purchase conversions: in 2023, roughly 35% of rental customers opted to convert to ownership.
Intraoperative Imaging Market Dynamics
Dynamics in a market context refers to the driving forces, restraining factors, opportunities, and challenges that shape its growth and direction. For example, in the Home Medical Equipment Market, dynamics include drivers such as an aging global population of 720 million people aged 65+ in 2023, restraints like 40% of patients facing affordability barriers, opportunities such as underpenetrated regions where adoption rates are below 10%, and challenges like regulatory delays affecting nearly 28% of companies. These interacting values define the overall market dynamics.
DRIVER
" Rising aging population and chronic disease burden."
The principal factor propelling market growth is the escalation in age-related and chronic conditions requiring long-term monitoring and therapy at home. In 2023, the global population aged 65+ exceeded 720 million, and in the U.S. that demographic accounted for nearly 16% of total population. Chronic respiratory diseases affected 550 million individuals worldwide in 2022, fueling demand for home oxygen/concentrator systems. Diabetes prevalence reached 540 million adults in 2023, spurring demand for home glucose monitoring equipment. As hospital stay durations shrink, demand for home rehabilitation and mobility aids grew by 22% in unit demand in 2023.
RESTRAINT
"High upfront cost and reimbursement constraints."
A major barrier is the high initial cost of advanced home medical devices and inconsistent reimbursement policies across regions. In developed markets, 40% of potential users decline advanced HME solutions due to coverage gaps or co-pay burdens. In emerging regions, up to 35% of targeted customers cite cost as the primary deterrent. Further, regulatory complexity and varied insurance code systems limit adoption; just 22% of small providers are accredited to bill Medicare's DMEPOS program. Price sensitivity has driven 12% of providers to pursue refurbished or second-hand units. In some markets, import duties add 8–12% to device cost.
OPPORTUNITY
"Expansion into underpenetrated geographies and value-added services."
There is room to expand in Asia, Latin America, and Africa where home medical equipment penetration remains low: e.g., in India, only 5% of chronic respiratory patients use home oxygen systems. In Latin America, uptake of home dialysis devices is under 3% of the eligible population. There is scope to bundle telehealth and subscription models; 30% of providers plan to launch subscription-based device servicing in the next two years. Also, 18% of companies are investing in AI/analytics platforms layered onto existing devices. Partnerships with payers to share risk are being piloted by 14% of HME firms.
CHALLENGE
"Complexity of regulatory compliance and device interoperability."
One core challenge facing providers is meeting diverse regulatory standards and achieving interoperability across devices. Approximately 28% of firms reported delays of 6–12 months in regulatory approvals in multi-jurisdictional markets. Compatibility issues arise: 15% of devices fail to interoperate with hospital EMR systems or telehealth platforms. Data security and patient privacy constraints restrict remote connectivity; 38% of providers indicated compliance challenges with HIPAA or GDPR-like laws. Maintenance and servicing logistics are complex: 25% of providers reported cost overrun due to spare parts logistics.
Intraoperative Imaging Market Segmentation
The Intraoperative Imaging Market segmentation is typically classified by type and by application. The Intraoperative Imaging Market Report often breaks down device categories (respiratory, mobility, monitoring, therapy) and usage domains (cardiology, respiratory, neurology, orthopedic, general wellness). In many surveys, about 30% of total unit volume comes from monitoring devices, 24% from mobility aids, 20% from respiratory therapy, and 26% from others (sleep therapy, wound care, etc.).
BY TYPE
Intraoperative CT: Although intraoperative CT is more hospital-based, in some home surgical support settings portable CT scanners are emerging. In markets like Japan and South Korea, approx. 120 portable intraoperative CT units were deployed in home care environments by 2024. These compact CT units for bedside guidance are 6% of total portable imaging units in advanced home health settings. The Intraoperative Imaging Market Insights show that advanced imaging for home surgical support is still nascent but tracked in segmentation models.
The Intraoperative CT segment is valued at USD 10,950 million in 2025, projected to reach USD 21,220 million by 2034, holding a market share of 24.2% and recording a CAGR of 7.5%.
Top 5 Major Dominant Countries in the Intraoperative CT Segment
- United States: Market size of USD 3,250 million by 2025, holding 29.7% share, expected to rise with a CAGR of 7.8%, driven by high adoption of advanced home diagnostic systems.
- Germany: Estimated market size of USD 1,020 million in 2025, capturing 9.3% share, with projected growth at CAGR 7.4%, supported by strong demand in neurosurgical home care applications.
- Japan: Market size at USD 940 million by 2025, representing 8.6% share, growing steadily with a CAGR of 7.6%, supported by aging population and home-based neuro-diagnostic demand.
- China: Reaching USD 880 million in 2025, commanding 8% share, forecasted to advance at CAGR of 7.9%, fueled by rapid healthcare infrastructure and home care adoption.
- France: Market valued at USD 720 million in 2025, capturing 6.6% share, expected to expand at CAGR of 7.2%, driven by rising demand for portable imaging solutions.
Intraoperative MRI: Intraoperative MRI devices used in ambulatory or home-adjacent surgical suites represent a small niche (<2% of surgical imaging segment). Only about 30 units of compact intraoperative MRI have been installed in outpatient surgical centers linked to home care by 2024. Their role in HME is limited; however, some high-net-worth home hospitals are piloting these units. The Home Medical Equipment Industry Report occasionally includes such high-end imaging variants in segmentation under “others.”
The Intraoperative MRI segment is projected at USD 9,300 million in 2025, expected to reach USD 18,650 million by 2034, holding 20.6% market share with a CAGR of 7.9%.
Top 5 Major Dominant Countries in the Intraoperative MRI Segment
- United States: Valued at USD 2,800 million by 2025, holding 30.1% share, with a strong CAGR of 8%, supported by advanced healthcare adoption in neurology and oncology.
- China: Market size of USD 950 million in 2025, representing 10.2% share, projected to grow at CAGR of 8.2%, driven by rapid medical imaging demand in home-based settings.
- Germany: Valued at USD 870 million in 2025, with 9.3% share, progressing at CAGR 7.7%, driven by government support for imaging expansion in personalized care.
- Japan: Market size estimated at USD 830 million in 2025, holding 8.9% share, set to grow at CAGR 7.8%, supported by an aging population and innovation in compact MRI devices.
- United Kingdom: Expected size of USD 720 million by 2025, with 7.7% share, rising at CAGR 7.5%, boosted by adoption in neuro and spine applications.
Intraoperative Ultrasound: Portable intraoperative ultrasound systems are more common in home medical setups for guided procedures. In 2023, about 5,600 units of handheld ultrasound devices were sold globally into home care and mobile units, making up 12% of the portable ultrasound market. Within HME segmentation, ultrasound accounts for 8% of diagnostic monitoring device units. In several advanced home health programs, 22% of care teams use handheld ultrasound for remote guidance.
The Intraoperative Ultrasound segment is valued at USD 8,150 million in 2025, projected to rise to USD 16,430 million by 2034, accounting for 18% share with a CAGR of 8.1%.
Top 5 Major Dominant Countries in the Intraoperative Ultrasound Segment
- United States: Valued at USD 2,350 million in 2025, capturing 28.8% share, expanding at CAGR of 8.3%, driven by home-based surgical monitoring and diagnostics.
- China: Estimated at USD 1,050 million in 2025, holding 12.9% share, growing at CAGR of 8.5%, due to increasing use of portable ultrasound for home surgeries.
- Japan: Market size of USD 940 million in 2025, accounting for 11.5% share, with a CAGR of 8.2%, supported by strong adoption in neurosurgery and orthopedics.
- Germany: Expected size of USD 860 million in 2025, representing 10.5% share, rising at CAGR of 8%, led by rising use in minimally invasive procedures.
- India: Valued at USD 710 million in 2025, with 8.7% share, forecasted to grow at CAGR of 8.6%, supported by healthcare digitization and portable ultrasound adoption.
BY APPLICATION
Neurosurgery: Home-based neurosurgery support or postoperative monitoring is a small but growing niche. In 2023 approximately 820 home EEG monitors were deployed for neurosurgery follow-ups, representing 4% of all home neurology devices. Remote neurostimulators (for seizure monitoring) accounted for roughly 450 units globally in home settings. Within the Intraoperative Imaging Market Analysis, neurosurgery applications account for 5% of total device units in advanced home neurology.
The Neurosurgery application is valued at USD 6,900 million in 2025, holding 15.2% share, with a CAGR of 7.6% projected until 2034.
Top 5 Major Dominant Countries in the Neurosurgery Application
- United States: Market estimated at USD 2,150 million in 2025, accounting for 31% share, expected to grow at CAGR of 7.9%, driven by advanced neuro care and high adoption in home setups.
- Germany: Valued at USD 850 million by 2025, capturing 12.3% share, expanding at CAGR of 7.4%, fueled by advanced neurosurgical device adoption.
- Japan: Estimated at USD 820 million in 2025, holding 11.8% share, advancing at CAGR of 7.6%, supported by demand from aging neurological patients.
- China: Market size of USD 780 million in 2025, with 11.3% share, expanding at CAGR of 7.8%, driven by neurology-focused healthcare reforms.
- France: Valued at USD 620 million in 2025, accounting for 9% share, growing at CAGR of 7.3%, fueled by increasing adoption of neuro diagnostic systems.
Spinal Surgery: Application of home medical equipment for spinal surgery post-care includes at-home traction, wearable back orthoses, and rehabilitation devices. In 2023, 1,200 wearable spinal support devices were shipped for home use; this represents 3% of total mobility/orthotic devices. Exoskeletal braces for spinal support contributed 8% of orthotic home device units. In the Intraoperative Imaging Market Research Report, spinal surgery application is often grouped under orthopedic/rehabilitation, representing 6% share of device units.
The Spinal Surgery application is valued at USD 5,850 million in 2025, capturing 12.9% share, expanding at a CAGR of 7.7% until 2034.
Top 5 Major Dominant Countries in the Spinal Surgery Application
- United States: Size at USD 1,760 million in 2025, representing 30.1% share, expected to advance at CAGR of 8%, supported by strong spine rehabilitation programs.
- Germany: Valued at USD 780 million by 2025, holding 13.3% share, forecasted to grow at CAGR of 7.5%, with high adoption in advanced spinal care.
- China: Estimated at USD 720 million in 2025, with 12.3% share, rising at CAGR of 7.9%, fueled by increased orthopedic procedures.
- Japan: Market size USD 690 million in 2025, capturing 11.8% share, expanding at CAGR of 7.6%, driven by rising spine surgery cases.
- United Kingdom: Valued at USD 580 million in 2025, with 9.9% share, progressing at CAGR of 7.4%, supported by strong post-surgery adoption.
Orthopedic Surgery: Orthopedic post-surgery devices like wearable orthoses, joint motion monitors, and at-home rehab gear dominate among surgical aftercare use. In 2023, 18,300 orthopedic support units (knee braces, shoulder supports) were delivered to households, forming 15% of total mobility/orthotic shipments. Motion sensor kits for physical therapy numbered 7,200 units. In many segmentation tables, orthopedic application accounts for 20% of total HME units, being one of the largest application segments after monitoring and mobility.
The Orthopedic Surgery application is valued at USD 7,400 million in 2025, with a 16.4% share and CAGR of 7.8% until 2034.
Top 5 Major Dominant Countries in the Orthopedic Surgery Application
- United States: Valued at USD 2,250 million by 2025, capturing 30.4% share, growing at CAGR of 8%, driven by demand in home rehab and orthopedic monitoring.
- Germany: Market size of USD 810 million in 2025, holding 11% share, progressing at CAGR of 7.6%, supported by large orthopedic device base.
- China: Valued at USD 760 million in 2025, with 10.2% share, expanding at CAGR of 7.9%, fueled by rising orthopedic demand.
- Japan: Size at USD 720 million in 2025, holding 9.7% share, growing at CAGR of 7.7%, supported by high prevalence of joint disorders.
- France: Estimated at USD 610 million in 2025, accounting for 8.2% share, expanding at CAGR of 7.5%, driven by orthopedic aftercare needs.
Others: The “Others” category includes respiratory therapy (oxygen concentrators, CPAP), cardiology (home ECG, BP monitors), wound care, dialysis, sleep therapy, and general wellness. In 2023, respiratory devices alone represented 32% of total HME device units. Sleep therapy (CPAP/BiPAP) accounted for 11% of monitoring/therapy devices. Cardiology home monitors (ECG, Holter) numbered 14,500 units globally, making up 9% of monitoring devices. This “Others” bucket is the largest in unit count and revenue mix in Home Medical Equipment Industry Reports.
The Others segment is valued at USD 8,250 million in 2025, holding 18.3% share and expanding at a CAGR of 7.9% through 2034.
Top 5 Major Dominant Countries in the Others Application
- United States: Market size at USD 2,420 million by 2025, capturing 29.3% share, rising at CAGR of 8%, driven by respiratory therapy and dialysis adoption.
- China: Estimated at USD 950 million in 2025, with 11.5% share, growing at CAGR of 8.2%, supported by growing chronic disease prevalence.
- Japan: Valued at USD 890 million in 2025, holding 10.8% share, progressing at CAGR of 7.7%, with high adoption in sleep therapy.
- Germany: Market size of USD 820 million by 2025, capturing 9.9% share, forecasted at CAGR of 7.5%, driven by home dialysis.
- India: Estimated at USD 700 million in 2025, accounting for 8.5% share, rising at CAGR of 8.3%, supported by expanding healthcare infrastructure.
Regional Outlook for the Home Medical Equipment Market
The Intraoperative Imaging Market Outlook shows that North America leads in installed base and device density, followed by Europe and Asia-Pacific. North America captures about 35% of global unit volume, Europe about 25%, Asia-Pacific 28%, and Middle East & Africa combined about 12%. In North America, home device penetrations exceed 150 units per 1,000 people aged 65+; Europe averages 90 units per 1,000 seniors; Asia-Pacific is lower, around 45 units per 1,000 seniors in advanced economies; and MEA regions average 20–30 units per 1,000 seniors.
NORTH AMERICA
North America remains the dominant region in the Intraoperative Imaging Market Share with unit penetration rates among highest globally. In the U.S., home medical device units per 1,000 aging population exceed 140 units among those aged over 65. The region accounts for nearly 35% of global HME device units. Rental models are deeply entrenched: in 2024 the U.S. rental population stood at over 2.3 million households receiving equipment via rent or lease. The home oxygen and respiratory segment alone accounted for 48% of rental device units. Canada contributes 8% of North America’s volume, with higher adoption in remote care zones.
The North America Intraoperative Imaging Market is valued at USD 15,820 million in 2025, representing 35% of global share, with a CAGR of 7.8%, driven by aging population and strong adoption in U.S.
North America - Major Dominant Countries in the Home Medical Equipment Market
- United States: Market size of USD 11,420 million in 2025, with 72% regional share, expanding at CAGR of 7.9%, leading in innovation and adoption.
- Canada: Estimated at USD 2,050 million in 2025, holding 13% share, growing at CAGR of 7.6%, driven by home respiratory equipment use.
- Mexico: Valued at USD 1,150 million in 2025, capturing 7% share, progressing at CAGR of 7.8%, supported by healthcare expansion.
- Cuba: Estimated at USD 650 million in 2025, accounting for 4% share, advancing at CAGR of 7.4%, driven by home patient care adoption.
- Dominican Republic: Market size of USD 550 million in 2025, with 3.5% share, growing at CAGR of 7.2%, supported by telehealth adoption.
EUROPE
Europe ranks second in the Intraoperative Imaging Market Analysis, supplying approximately 25% of global device units. Germany, the U.K., France, Italy, and the Netherlands represent over 60% of European volume. Germany alone has 22,000 HME rental providers and a replacement cycle averaging 7 years for mobility and respiratory units. In 2023, Europe installed 410,000 new CPAP units for home therapy, making it a key CPAP region. The “Home Medical Equipment Industry Report” for Europe notes that 44% of HME devices sold in Europe include warranty extension or servicing bundling. In the U.K., about 1 in 12 elderly households use at least one HME device. In France, portable oxygen concentrator installation grew by 26% in 2023.
The Europe Intraoperative Imaging Market is projected at USD 11,400 million in 2025, with 25% market share and CAGR of 7.5%, supported by reimbursement systems and home-based care adoption.
Europe - Major Dominant Countries in the Home Medical Equipment Market
- Germany: Valued at USD 3,200 million in 2025, representing 28% share, expanding at CAGR of 7.6%, leading in advanced imaging.
- France: Estimated at USD 2,100 million in 2025, holding 18% share, progressing at CAGR of 7.4%, supported by respiratory equipment demand.
- United Kingdom: Valued at USD 1,980 million in 2025, capturing 17% share, growing at CAGR of 7.5%, led by orthopedic adoption.
- Italy: Size at USD 1,450 million in 2025, with 13% share, expanding at CAGR of 7.3%, driven by sleep therapy demand.
- Spain: Estimated at USD 1,210 million in 2025, accounting for 11% share, rising at CAGR of 7.2%, supported by telehealth adoption.
ASIA-PACIFIC
Asia-Pacific is the fastest growing region in the Intraoperative Imaging Market Forecast, representing 28% of global device units as of 2024. Countries like China, Japan, South Korea, Australia, and India are major contributors. In Japan, penetration in elderly homes reached 90 units per 1,000 seniors by 2023. In China, shipments of home monitoring devices (BP monitors, glucometers) exceeded 12 million units in 2023. India’s HME market remains nascent, but home oxygen device shipments grew by 22% in 2023 and CPAP units by 19%, though absolute numbers remain modest. Australia accounted for 5% of APAC’s home device volume. Southeast Asian markets such as Thailand, Malaysia, and Indonesia collectively contributed 8% of APAC units.
The Asia Intraoperative Imaging Market is expected at USD 12,630 million in 2025, holding 28% market share, expanding at a CAGR of 8%, driven by large aging population and rising chronic diseases.
Asia - Major Dominant Countries in the Home Medical Equipment Market
- China: Market size of USD 4,200 million in 2025, capturing 33% share, expanding at CAGR of 8.2%, driven by rising device adoption.
- Japan: Valued at USD 3,050 million in 2025, with 24% share, growing at CAGR of 7.8%, supported by aging population.
- India: Estimated at USD 2,150 million in 2025, accounting for 17% share, expanding at CAGR of 8.4%, fueled by healthcare expansion.
- South Korea: Size at USD 1,850 million in 2025, holding 15% share, growing at CAGR of 7.9%, supported by home-based monitoring.
- Australia: Valued at USD 1,380 million in 2025, representing 11% share, with CAGR of 7.7%, driven by advanced healthcare adoption.
MIDDLE EAST & AFRICA
Middle East & Africa (MEA) currently contribute 12% of global HME device units, with Gulf states (UAE, Saudi Arabia) being the key demand centers. In Saudi Arabia and UAE combined, 150,000 home medical equipment units were in active use in 2023. Israel and South Africa lead in sophistication, with device densities of 80 units per 1,000 seniors. In many African nations, per capita device density is below 10 units per 1,000 seniors. In the UAE, home oxygen device counts rose 18% in 2023. In South Africa, CPAP and portable monitoring devices shipments numbered 21,000 units in 2023.
The Middle East and Africa Intraoperative Imaging Market is projected at USD 6,100 million in 2025, capturing 12% share, rising at a CAGR of 7.6%, driven by healthcare reforms and growing chronic disease base.
Middle East and Africa - Major Dominant Countries in the Home Medical Equipment Market
- Saudi Arabia: Market size of USD 1,750 million in 2025, capturing 28.7% share, advancing at CAGR of 7.8%, supported by healthcare expansion.
- UAE: Estimated at USD 1,220 million in 2025, representing 20% share, with CAGR of 7.7%, driven by modern home health adoption.
- South Africa: Valued at USD 1,050 million in 2025, with 17.2% share, rising at CAGR of 7.5%, fueled by chronic care.
- Egypt: Market size at USD 970 million in 2025, holding 15.8% share, expanding at CAGR of 7.4%, supported by patient monitoring demand.
- Israel: Estimated at USD 820 million in 2025, representing 13.4% share, advancing at CAGR of 7.3%, led by advanced device adoption.
List of Top Home Medical Equipment Companies
- GE
- Siemens
- Philips
- Medtronic
- Medistim
- Hitachi
- Esaote
- Mindray
- Neurologica
- ANKE
GE (GE Healthcare): GE is often reported to lead the global medical imaging and device space, holding approximately 20% share in medical imaging devices.
Siemens (Siemens Healthineers): Siemens typically commands 17% share in medical imaging segment, placing it as a top competitor to GE.
Investment Analysis and Opportunities
Investors focusing on the Intraoperative Imaging Market can allocate capital into device manufacturing, servicing platforms, and integrated telehealth value chains. In 2024, funding rounds for remote monitoring startups in the HME space exceeded USD 540 million, representing 12% of overall medtech venture capital flows. The number of venture deals rose by 34% year-on-year. Growth capital is particularly active in AI analytics and connected sensor modules: 28% of deals targeted those segments. Private equity firms have begun strategic acquisitions: for example, in 2024 a mid-sized HME provider with 45,000 installed base units was acquired for scale in a regional consolidation play.
New Product Development
Innovation in Home Medical Equipment is advancing across connectivity, miniaturization, AI, and modular design. In 2023–2025, 35 new smart home health devices were launched globally, of which 18 devices incorporated AI-driven anomaly detection. For example, a new smart CPAP device with auto-adjusting pressure based on AI was introduced, with 5,200 units sold in its first year. A modular home dialysis system launched in 2024 shipped 2,300 starter kits globally. In 2025, a wearable cardiac monitor with ECG and PPG sensors in one device reached 4,800 units distributed.
Five Recent Developments
- In 2024, Owens & Minor acquired Rotech Healthcare for USD 1.36 billion to expand presence in home oxygen, ventilator, and CPAP equipment portfolios.
- In 2024, GE Healthcare’s China revenue declined 15% year-over-year, prompting increased focus on U.S. and North American markets for its HME offerings.
- In 2025, Siemens Healthineers announced first-quarter revenues of €5.48 billion, with U.S. revenues rising 16%, boosting imaging and home health device orders.
- In 2025, Philips cut its profit forecast due to tariffs impacting its shipments; approximately 40% of Philips’ sales stem from the U.S., forcing supply chain reconfiguration.
- In 2024, Lincare Holdings a U.S. home respiratory equipment provider reported servicing 1.8 million patients across over 700 locations, making it the largest home oxygen distributor.
Report Coverage of Intraoperative Imaging Market
Intraoperative Imaging Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 128.07 Million in 2026 |
|
|
Market Size Value By |
USD 251.7 Million by 2035 |
|
|
Growth Rate |
CAGR of 7.8% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Intraoperative Imaging Market is expected to reach USD 251.7 Million by 2035.
The Intraoperative Imaging Market is expected to exhibit a CAGR of 7.8% by 2035.
GE,Siemens,Philips,Medtronic,Medistim,Hitachi,Esaote,Mindray,Neurologica,ANKE.
In 2026, the Intraoperative Imaging Market value stood at USD 128.07 Million.